Companies / Kezar Life Sciences, Inc.

Kezar Life Sciences, Inc.

Nasdaq: KZRCIK 1645666SOUTH SAN FRANCISCO, CA

Financials · FY2025

Revenue$0
Net income$-56.03M
Total debt$0
Cash$66.23M
Diluted EPS$-7.66
Shares outstanding7.4M

Ownership

7.4M shares outstanding · as of May 7, 2026
9.8%10%+ / strategic
Ownership
10%+ / strategic9.76%720,787
Institutions0.00%1
Public float90.24%6,666,913

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Belsky MarcChief Financial Officer
0.00%0
0.00%0
0.00%0

Institutional holders 1

View all →
HolderValue% of shares
Barclays PLC$1<0.01%

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 11, 2026Cooper Graham K
Director
OtherStock Option (right to buy)-3K
-100.00%
0
0.00% of shares
low
May 11, 2026Cooper Graham K
Director
OtherStock Option (right to buy)-3K
-100.00%
0
0.00% of shares
low
May 11, 2026Cooper Graham K
Director
OtherStock Option (right to buy)-3K
-100.00%
0
0.00% of shares
low
May 11, 2026Cooper Graham K
Director
OtherStock Option (right to buy)-889
-100.00%
0
0.00% of shares
low
May 11, 2026Cooper Graham K
Director
OtherStock Option (right to buy)-889
-100.00%
0
0.00% of shares
low
May 11, 2026Cooper Graham K
Director
OtherStock Option (right to buy)-5K
-100.00%
0
0.00% of shares
low
May 11, 2026Cooper Graham K
Director
OtherStock Option (right to buy)-5K
-100.00%
0
0.00% of shares
low
May 11, 2026Cooper Graham K
Director
OtherStock Option (right to buy)-4K
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
BML Investment Partners, L.P.Passive13G/A720,787
Stonepine Capital Management, LLCPassive13G/A
BML Investment Partners, L.P.Passive13G/A0

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
KZR49372L100